The SCOT-HEART trial provides critical insights into coronary artery disease development among individuals who initially displayed normal coronary arteries. While a normal coronary computed tomography (CT) angiogram usually indicates low short-term risk, long-term progression remains a concern for clinicians. Consequently, researchers evaluated patients over a median of 9.3 years to identify how many developed new plaques. Findings suggest that even a \”clean\” scan does not guarantee lifelong protection against atherosclerosis.
Understanding Coronary Artery Disease Development
Researchers analyzed 524 patients who had normal coronary arteries at the start of the SCOT-HEART trial. Over the follow-up period, nearly half of those who underwent repeat imaging showed signs of disease. Specifically, 48% of patients who had a repeat CCTA and 25% of those with chest CTs were diagnosed with CAD. Therefore, clinicians should recognize that coronary artery disease development can occur significantly within a decade. This highlight emphasizes the need for continuous risk factor management even after a negative initial scan.
Long-Term Imaging and Patient Outcomes
The study found that the median time to identify new CAD was approximately 8.1 years. Surprisingly, the appearance of new disease did not lead to a significant increase in all-cause mortality or myocardial infarction within this group. However, those with newly identified CAD were nearly five times more likely to undergo invasive coronary angiography. Furthermore, these patients frequently required a higher intensity of preventive medical therapies. This suggests that while mortality remained stable, the clinical burden and healthcare utilization increased significantly.
Clinical Implications for Indian Physicians
In the Indian context, where premature CAD is highly prevalent, these findings are particularly relevant. Patients often perceive a normal CT scan as a permanent clearance of heart health. However, this data proves that atherosclerosis is a progressive condition that requires vigilant monitoring of cardiovascular risk factors. Moreover, the increased likelihood of invasive procedures highlights the importance of early lifestyle interventions. Indian doctors should use these insights to encourage long-term adherence to heart-healthy habits, regardless of baseline imaging results.
Frequently Asked Questions
Q1: How likely are patients with normal coronary arteries to develop CAD later?
Research indicates that approximately 48% of patients who undergo repeat CCTA after nine years will show signs of coronary artery disease development.
Q2: Does developing new CAD after a normal scan increase the risk of death?
The study did not find a significant difference in all-cause mortality or non-fatal myocardial infarction between those who developed CAD and those who did not.
Q3: How does a new diagnosis of CAD affect patient management?
Patients with new CAD are significantly more likely to undergo invasive coronary angiography and require adjustments to their preventive medications.
References
- Avigdor L et al. Development of coronary artery disease in patients with initially normal coronary arteries in the SCOT-HEART trial. Eur Radiol. 2026 Mar 05. doi: 10.1007/s00330-026-12353-6. PMID: 41781727.
- Newby DE, et al. Coronary CT angiography and 5-year risk of myocardial infarction. N Engl J Med 2018; 379: 924–33.
- Williams MC, et al. Coronary CT angiography-guided management of patients with stable chest pain: 10-year outcomes from the SCOT-HEART randomised controlled trial in Scotland. Lancet 2025; 405: 329-37.